Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Accruing data suggest that oxidative stress may be a factor underlying the pathophysiology of bipolar disorder (BD), major depressive disorder (MDD), and schizophrenia (SCZ). Glutathione (GSH) is the major free radical scavenger in the brain. Diminished GSH levels elevate cellular vulnerability towards oxidative stress; characterized by accumulating reactive oxygen species. The aim of this study was to determine if mood disorders and SCZ are associated with abnormal GSH and its functionally related enzymes. Post-mortem prefrontal cortex from patients with BD, MDD, SCZ, and from non-psychiatric comparison controls were provided by the Stanley Foundation Neuropathology Consortium. Spectrophotometric analysis was utilized for the quantitative determination of GSH, while immunoblotting analyses were used to examine expression of glutamyl-cysteine ligase (GCL), GSH reductase (GR), and GSH peroxidase (GPx). We found that the levels of reduced, oxidized, and total GSH were significantly decreased in all psychiatric conditions compared to the control group. Although GCL and GR levels did not differ between groups, the levels of GPx were reduced in MDD and SCZ compared to control subjects. Since oxidative damage has been demonstrated in MDD, BD, and SCZ, our finding that GSH levels are reduced in post-mortem prefrontal cortex suggests that these patient groups may be more susceptible to oxidative stress.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“increased oxidative stress, lower antioxidant levels, and imbalanced oxidant:antioxidant levels have been well documented within the hippocampus (103,104) and mPFC (104–106), resulting in associated markers of DNA/RNA damage in these regions.”
From The Impact of Stress and Major Depressive Disorder on Hippocampal and Medial Prefrontal Cortex Morphology (2019) · cites this paper as [106]
In the citing paper
“Reduced antioxidant enzymes are reported in schizophrenic patients (4–8)”
From Prolonged Period of Cortical Plasticity upon Redox Dysregulation in Fast-Spiking Interneurons (2015) · cites this paper as [8]
In the citing paper
“Emerging evidence shows that PNNs may play a key role in protecting neurons from oxidative stress, such as it may be caused by a decrease of glutathione, a key brain antioxidant found to be decreased in SZ (Cabungcal et al., 2013; Gawryluk et al., 2011; Suttkus et al., 2014).”
From Losing the sugar coating: Potential impact of perineuronal net abnormalities on interneurons in schizophrenia (2015) · cites this paper as Gawryluk et al., 2011
In the citing paper
“In an animal model with low GSH content, as reported in the brain of some schizophrenia patients (Do et al., 2000; Gawryluk et al., 2011; Yao et al., 2006), there is a deficit in prefrontal and hippocampal PVI, impairing high-frequency neuronal synchronization (Cabungcal et al., 2013a; Cabungcal et al., 2013b; Steullet et al., 2010).”
From Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A “central hub” in schizophrenia pathophysiology? (2016) · cites this paper as Gawryluk et al., 2011
In the citing paper
“Plasma glutathione peroxidase levels have been found to be lowered in schizophrenia patients (Gawryluk et al. 2011) as well as in psychotic children (Golse et al. 1977).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Gawryluk et al. 2011
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Free radicals in biology and medicine
(1991) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178
Glutathione metabolism and its selective modification.
Meister, A. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77815-6 · Cited by 2,011
Metabolism and functions of glutathione in brain
Dringen, R. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00060-x · Cited by 1,702 · cited 1×
“Glutathione (GSH) is the brain’s major antioxidant system (Dringen, 2000) and plays a key role against oxidative stress.”
Halliwell, B. (2001) · Drugs & Aging · doi:10.2165/00002512-200118090-00004 · Cited by 1,502
Journal of Psychiatry and Neuroscience
(2025) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn · Cited by 1,128
Oxidative stress in psychiatric disorders: evidence base and therapeutic implications
Ng, F., Berk, M., Dean, O., & Bush, A. I. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008401 · Cited by 1,069 · cited 1×
“All of these studies together suggest that oxidative stress may play a significant role in the pathophysiology of psychiatric illness (Ng et al. 2008).”
Prabakaran, S., Swatton, J. E., Ryan, M. M., Huffaker, S. J., Huang, J.-J., Griffin, J. L., Wayland, M., Freeman, T., Dudbridge, F., Lilley, K. S., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001511 · Cited by 971 · cited 1×
“Similar findings have also been reported in prefrontal cortex from SCZ patients (Prabakaran et al. 2004).”
Lucy, J. A. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80903-0 · Cited by 907
Bilici, M., Efe, H., Köroğlu, M. A., Uydu, H. A., Bekaroğlu, M., & Değer, O. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00199-3 · Cited by 718 · cited 5×
“Peripheral studies on psychiatric illnesses have reported increased activity of GR in MDD (Bilici et al. 2001 ; Kodydkova et al. 2009) but to our knowledge no changes have been observed in SCZ or BD. Studies on GPx in patients with psychiatric illness have been inconsistent.”
InfluentialBerk, M., Copolov, D., Dean, O., Lu, K., Jeavons, S., Schapkaitz, I., Anderson-Hunt, M., Judd, F., Katz, F., Katz, P., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.004 · Cited by 552 · cited 2×
“…the clinic ; double-blinded, randomized, placebo-controlled trials have demonstrated that NAC improves the positive and negative symptoms of SCZ (Berk et al. 2008b) and the depressive symptoms of BD patients (Berk et al. 2008a), which via immunoblotting analyses in Con, SCZ, MDD, and BD patients.”
Cited by
Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging
Jomova, K., Raptova, R., Alomar, S. Y., Alwasel, S. H., Nepovimova, E., Kuca, K., & Valko, M. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03562-9 · Cited by 2,638
Oxidative Stress and the Central Nervous System
Salim, S. (2017) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.237503 · Cited by 1,247
“Increased levels of ROS and RNS (Suzuki and Colasanti, 2001; Dhir and Kulkarni, 2011; Maes et al., 2011) and altered levels of antioxidant glutathione (GSH) were reported in postmortem brain samples of depressed individuals (Gawryluk et al., 2011).”
Is depression associated with increased oxidative stress? A systematic review and meta-analysis
Black, C. N., Bot, M., Scheffer, P. G., Cuijpers, P., & Penninx, B. W. J. H. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.09.025 · Cited by 711
Belleau, E. L., Treadway, M. T., & Pizzagalli, D. A. (2019) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.09.031 · Cited by 550
Oxidative Stress and Psychological Disorders
Salim, S. (2014) · Current Neuropharmacology · doi:10.2174/1570159x11666131120230309 · Cited by 557
“Furthermore, the GSH-Px levels were reported to be lower in schizophrenia patients as compared to controls, in schizophrenic patients on neuroleptics [74, 94-97] and psychotic children [98] with the exception of one report where markedly increased GSH-Px activity was observed [86] which may indicate the differences in…”
BackgroundResult
Metadata
- Authors
- Gawryluk, J. W., Wang, J.-F., Andreazza, A. C., Shao, L., & Young, L. T.
- Affiliations
- University of British Columbia (CA)
- Corresponding author
- Young, L. Trevor
- Venue
- The International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-07-16
- Volume
- 14
- Issue
- 01
- Pages
- 123-130
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- OpenAlex
- W2103127225
- Cited by
- 594
- References
- 41
- Citations by year
- 2026: 23 · 2025: 31 · 2024: 31 · 2023: 37 · 2022: 39 · 2021: 42 · 2020: 49 · 2019: 33 · 2018: 38 · 2017: 47 · 2016: 41 · 2015: 46 · 2014: 48 · 2013: 36 · 2012: 31
- FWCI
- 11.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- glutathione, oxidative stress, prefrontal cortex, bipolar disorder, major depressive disorder, schizophrenia, glutathione peroxidase, glutathione reductase, mood disorders, postmortem brain
- MeSH terms
- Aging, Antioxidants, Bipolar Disorder, Major Depressive Disorder, Depressive Disorder, Major, Female, Glutathione, Glutathione Peroxidase, Glutathione Reductase, Humans, Hydrogen-Ion Concentration, Male, Oxidation-Reduction, Schizophrenia, Reactive Oxygen Species, Prefrontal Cortex, Oxidative Stress, Substance-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. https://app.cochat.ai/papers/10.1017/s1461145710000805
- The paper
- Gawryluk, J. W., Wang, J.-F., Andreazza, A. C., Shao, L., & Young, L. T. (2011). Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. The International Journal of Neuropsychopharmacology. https://doi.org/10.1017/s1461145710000805
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.